American Renal Associates Holdings Inc (NYSE:ARA)’s share price reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $22.20 and last traded at $22.33, with a volume of 62,472 shares trading hands. The stock had previously closed at $22.70.

Several equities research analysts recently commented on the stock. SunTrust Banks Inc. assumed coverage on shares of American Renal Associates Holdings in a report on Monday, May 16th. They issued a “buy” rating and a $34.00 price target for the company. Barclays PLC assumed coverage on shares of American Renal Associates Holdings in a report on Monday, May 16th. They issued an “overweight” rating and a $33.00 price target for the company. Zacks Investment Research raised shares of American Renal Associates Holdings from a “hold” rating to a “buy” rating and set a $29.00 price target for the company in a report on Monday, July 18th. Leerink Swann reissued an “outperform” rating on shares of American Renal Associates Holdings in a report on Monday, May 16th. Finally, Wells Fargo & Co. assumed coverage on shares of American Renal Associates Holdings in a report on Monday, May 16th. They issued an “outperform” rating for the company. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $31.80.

The stock has a 50 day moving average price of $0.00 and a 200-day moving average price of $0.00. The firm has a market capitalization of $485.71 million and a price-to-earnings ratio of 11.14.

American Renal Associates Holdings (NYSE:ARA) last announced its earnings results on Thursday, May 12th. The company reported $0.16 earnings per share (EPS) for the quarter. The business had revenue of $172.10 million for the quarter, compared to analysts’ expectations of $149.30 million. On average, equities research analysts forecast that American Renal Associates Holdings Inc will post $0.88 EPS for the current fiscal year.

American Renal Associates Holdings, Inc is a dialysis services provider in the United States. The Company focuses on joint venture partnerships with physicians. The Company’s segment is the ownership and operation of dialysis clinics. It provides patient care and clinical outcomes to patients suffering from the advanced stage of chronic kidney disease, known as end stage renal disease (ESRD).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.